1. Cell Biology
Download icon

A versatile Oblique Plane Microscope for large-scale and high-resolution imaging of subcellular dynamics

  1. Etai Sapoznik
  2. Bo-Jui Chang
  3. Jaewon Huh
  4. Robert J Ju
  5. Evgenia V Azarova
  6. Theresa Pohlkamp
  7. Erik S Welf
  8. David Broadbent
  9. Alexandre F Carisey
  10. Samantha J Stehbens
  11. Kyung-Min Lee
  12. Arnoldo Marin
  13. Ariella B Hanker
  14. Jens C Schmidt
  15. Carlos L Arteaga
  16. Bin Yang
  17. Yoshihiko Kobayashi
  18. Purushothama Rao Tata
  19. Rory Kruithoff
  20. Konstantin Dubrovinski
  21. Doug P Shepherd
  22. Alfred Millet-Sikking
  23. Andrew G York
  24. Kevin M Dean  Is a corresponding author
  25. Reto P Fiolka  Is a corresponding author
  1. University of Texas Southwestern Medical Center, United States
  2. University of Queensland, Australia
  3. Michigan State University, United States
  4. Baylor College of Medicine and Texas Children's Hospital, United States
  5. Chan Zuckerberg Biohub, United States
  6. Duke University, United States
  7. Arizona State University, United States
  8. Calico Life Sciences LLC, United States
Research Article
  • Cited 20
  • Views 22,761
  • Annotations
Cite this article as: eLife 2020;9:e57681 doi: 10.7554/eLife.57681

Abstract

We present an Oblique Plane Microscope that uses a bespoke glass-tipped tertiary objective to improve the resolution, field of view, and usability over previous variants. Owing to its high numerical aperture optics, this microscope achieves lateral and axial resolutions that are comparable to the square illumination mode of Lattice Light-Sheet Microscopy, but in a user friendly and versatile format. Given this performance, we demonstrate high-resolution imaging of clathrin-mediated endocytosis, vimentin, the endoplasmic reticulum, membrane dynamics, and Natural Killer-mediated cytotoxicity. Furthermore, we image biological phenomena that would be otherwise challenging or impossible to perform in a traditional light-sheet microscope geometry, including cell migration through confined spaces within a microfluidic device, subcellular photoactivation of Rac1, diffusion of cytoplasmic rheological tracers at a volumetric rate of 14 Hz, and large field of view imaging of neurons, developing embryos, and centimeter-scale tissue sections.

Data availability

Manuscript data is available on Zenodo, under the doi:10.5281/zenodo.4266823.

The following data sets were generated

Article and author information

Author details

  1. Etai Sapoznik

    Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8472-0299

  2. Bo-Jui Chang

    Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.

  3. Jaewon Huh

    Bioinformatics and Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.

  4. Robert J Ju

    Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia
    Competing interests
    No competing interests declared.

  5. Evgenia V Azarova

    Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.

  6. Theresa Pohlkamp

    Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3923-1917

  7. Erik S Welf

    Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.

  8. David Broadbent

    nstitute for Quantitative Health Sciences and Engineering, Michigan State University, East Lansing, United States
    Competing interests
    No competing interests declared.

  9. Alexandre F Carisey

    William T. Shearer Center for Human Immunobiology, Baylor College of Medicine and Texas Children's Hospital, Houston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1326-2205

  10. Samantha J Stehbens

    Institute for Molecular Bioscience, University of Queensland, St. Lucia, Queensland, Australia
    Competing interests
    No competing interests declared.

  11. Kyung-Min Lee

    Harold C Simmons Comprehensive Cancer Center and the Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.

  12. Arnoldo Marin

    Harold C Simmons Comprehensive Cancer Center and the Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.

  13. Ariella B Hanker

    Harold C Simmons Comprehensive Cancer Center and the Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.

  14. Jens C Schmidt

    OBGYN, Institute for Quantitative Health Sciences and Engineering, Michigan State University, East Lansing, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9061-7853

  15. Carlos L Arteaga

    Harold C. Simmons Comprehensive Cancer Center and the Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    Carlos L Arteaga, This author serves in an advisory role for Novartis, which has an investment interest in alpelisib..

  16. Bin Yang

    Chan Zuckerberg Biohub, Chan Zuckerberg Biohub, San Francisco, United States
    Competing interests
    No competing interests declared.

  17. Yoshihiko Kobayashi

    Department of Cell Biology, Duke University, Durham, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7031-1478

  18. Purushothama Rao Tata

    Department of Cell Biology, Duke University, Durham, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4837-0337

  19. Rory Kruithoff

    Department of Physics and the Center for Biological Physics, Arizona State University, Tempe, United States
    Competing interests
    No competing interests declared.

  20. Konstantin Dubrovinski

    Systems Biology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.

  21. Doug P Shepherd

    Department of Physics and the Center for Biological Physics, Arizona State University, Tempe, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9087-0832

  22. Alfred Millet-Sikking

    Calico Life Sciences LLC, South San Franscisco, United States
    Competing interests
    No competing interests declared.

  23. Andrew G York

    Calico Life Sciences LLC, South San Franscisco, United States
    Competing interests
    No competing interests declared.

  24. Kevin M Dean

    Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States
    For correspondence
    Kevin.Dean@UTsouthwestern.edu
    Competing interests
    Kevin M Dean, This author has an investment interest in Discovery Imaging Systems, LLC.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0839-2320

  25. Reto P Fiolka

    Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States
    For correspondence
    Reto.Fiolka@UTsouthwestern.edu
    Competing interests
    Reto P Fiolka, The author has an investment interest in Discovery Imaging Systems, LLC..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4636-5000

Funding

Cancer Prevention and Research Institute of Texas (RR160057)

  • Reto P Fiolka

National Institutes of Health (5P30CA142543)

  • Kevin M Dean

Damon Runyon Cancer Research Foundation (DFS-24-17)

  • Jens C Schmidt

Chan Zuckerberg Initiative (HCA3-0000000196)

  • Purushothama Rao Tata

Chan Zuckerberg Initiative (HCA3-0000000196)

  • Doug P Shepherd

Chan Zuckerberg Initiative (HCA3-0000000196)

  • Yoshihiko Kobayashi

ARC (FT190100516)

  • Samantha J Stehbens

Rebecca Cooper Medical Foundation (PG2018168)

  • Samantha J Stehbens

University of Queensland Early Career Award (RM2018002613)

  • Samantha J Stehbens

Company of Biologists (JCSTF1903138)

  • Robert J Ju

Robert A. Welch Foundation (I-1950-20180324)

  • Konstantin Dubrovinski

National Institutes of Health (R00 GM120386)

  • Jens C Schmidt

National Institutes of Health (R01GM110066)

  • Konstantin Dubrovinski

Human Frontiers Science Program Organization (LT000911/2018C)

  • Jaewon Huh

National Institutes of Health (R01HL068702)

  • Doug P Shepherd

National Institutes of Health (R33CA235254)

  • Reto P Fiolka

National Institutes of Health (R35GM133522)

  • Reto P Fiolka

National Institutes of Health (K25 CA204526)

  • Erik S Welf

National Institutes of Health (P30 CA142543)

  • Carlos L Arteaga

National Institutes of Health (1R01MH120131-01A1)

  • Kevin M Dean

National Institutes of Health (1R34NS121873)

  • Kevin M Dean

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Melike Lakadamyali, University of Pennsylvania, United States

Publication history

  1. Received: April 8, 2020
  2. Accepted: November 9, 2020
  3. Accepted Manuscript published: November 12, 2020 (version 1)
  4. Accepted Manuscript updated: November 16, 2020 (version 2)
  5. Version of Record published: December 1, 2020 (version 3)
  6. Version of Record updated: December 7, 2020 (version 4)
  7. Version of Record updated: February 1, 2021 (version 5)

Copyright

© 2020, Sapoznik et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 22,761
    Page views
  • 811
    Downloads
  • 20
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Categories and tags

Further reading

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine

    The IRE1/XBP1 signaling axis promotes skeletal muscle regeneration through a cell non-autonomous mechanism

    Anirban Roy et al.
    Research Article Updated

    Skeletal muscle regeneration is regulated by coordinated activation of multiple signaling pathways. The unfolded protein response (UPR) is a major mechanism that detects and alleviates protein-folding stresses in the endoplasmic reticulum. However, the role of individual arms of the UPR in skeletal muscle regeneration remain less understood. In the present study, we demonstrate that IRE1α (also known as ERN1) and its downstream target, XBP1, are activated in skeletal muscle of mice upon injury. Myofiber-specific ablation of IRE1α or XBP1 in mice diminishes skeletal muscle regeneration that is accompanied with reduced number of satellite cells. Ex vivo cultures of myofiber explants demonstrate that ablation of IRE1α reduces the proliferative capacity of myofiber-associated satellite cells. Myofiber-specific ablation of IRE1α dampens Notch signaling and canonical NF-κB pathway in skeletal muscle of adult mice. Finally, targeted ablation of IRE1α also reduces Notch signaling, abundance of satellite cells, and skeletal muscle regeneration in the mdx mice, a model of Duchenne muscular dystrophy. Collectively, our experiments suggest that the IRE1α-mediated signaling promotes muscle regeneration through augmenting the proliferation of satellite cells in a cell non-autonomous manner.

    1. Biochemistry and Chemical Biology
    2. Cell Biology

    Branched ubiquitin chain binding and deubiquitination by UCH37 facilitate proteasome clearance of stress-induced inclusions

    Aixin Song et al.
    Research Article Updated

    UCH37, also known as UCHL5, is a highly conserved deubiquitinating enzyme (DUB) that associates with the 26S proteasome. Recently, it was reported that UCH37 activity is stimulated by branched ubiquitin (Ub) chain architectures. To understand how UCH37 achieves its unique debranching specificity, we performed biochemical and Nuclear Magnetic Resonance (NMR) structural analyses and found that UCH37 is activated by contacts with the hydrophobic patches of both distal Ubs that emanate from a branched Ub. In addition, RPN13, which recruits UCH37 to the proteasome, further enhances branched-chain specificity by restricting linear Ub chains from having access to the UCH37 active site. In cultured human cells under conditions of proteolytic stress, we show that substrate clearance by the proteasome is promoted by both binding and deubiquitination of branched polyubiquitin by UCH37. Proteasomes containing UCH37(C88A), which is catalytically inactive, aberrantly retain polyubiquitinated species as well as the RAD23B substrate shuttle factor, suggesting a defect in recycling of the proteasome for the next round of substrate processing. These findings provide a foundation to understand how proteasome degradation of substrates modified by a unique Ub chain architecture is aided by a DUB.

    1. Cell Biology
    2. Neuroscience

    Ca2+/CaM binding to CaMKI promotes IMA-3 importin binding and nuclear translocation in sensory neurons to control behavioral adaptation

    Domenica Ippolito et al.
    Research Article Updated

    Sensory and behavioral plasticity are essential for animals to thrive in changing environments. As key effectors of intracellular calcium signaling, Ca2+/calmodulin-dependent protein kinases (CaMKs) can bridge neural activation with the many regulatory processes needed to orchestrate sensory adaptation, including by relaying signals to the nucleus. Here, we elucidate the molecular mechanism controlling the cell activation-dependent nuclear translocation of CMK-1, the Caenorhabditis elegans ortholog of mammalian CaMKI/IV, in thermosensory neurons in vivo. We show that an intracellular Ca2+ concentration elevation is necessary and sufficient to favor CMK-1 nuclear import. The binding of Ca2+/CaM to CMK-1 increases its affinity for IMA-3 importin, causing a redistribution with a relatively slow kinetics, matching the timescale of sensory adaptation. Furthermore, we show that this mechanism enables the encoding of opposite nuclear signals in neuron types with opposite calcium-responses and that it is essential for experience-dependent behavioral plasticity and gene transcription control in vivo. Since CaMKI/IV are conserved regulators of adaptable behaviors, similar mechanisms could exist in other organisms and for other sensory modalities.